skip to main |
skip to sidebar
Novel Radiotracer Shines New Light on the Brains of Alzheimer's Disease Patients
ScienceDaily (June 26, 2010) — A trial of a novel radioactive compound readily and safely distinguished the brains of Alzheimer's disease patients from healthy volunteers on brain scans and opens the doors to making such imaging available beyond facilities that can manufacture their own radioactive compounds. The results, reported by a Johns Hopkins team in the June Journal of Nuclear Medicine, could lead to better ways to distinguish Alzheimer's from other types of dementia, track disease progression and develop new therapeutics to fight the memory-ravaging disease.
No comments:
Post a Comment